Dr. Brajesh Barse

Senior Director, Lifesciences @ US-India Business Council , Ex Scientist, ICGEB & NIPER, MIUR Fellow (University of Cagliari, Italy)

[Ambassador Sergio Gor @USAmbIndia]

Stronger U.S.-India pharma ties mean more resilient supply chains for our people. Great roundtable with U.S. industry leaders today on expanding their footprint here while advocating for fair deals. We’re ensuring our most innovative companies lead the way in a competitive global market.

@EliLillyandCo @JNJNews @AbbottNews @pfizer @MSDInvents @abbvie @amgen @OrganonLLC @bmsnews @OPPIIndia

[U.S.-India Business Council @USIBC]

Dr Brajesh Barse, Director, Life Sciences, USIBC, participated in the Bharat Tribes Fest 2026: Business Conclave, contributing to an insightful panel on “Opening New Horizons: Increasing Exports of Products from Tribal Businesses” under the theme Market Access and Exports.

The session was chaired by Mr Anup Wadhawan, Former Commerce Secretary, Govt of India and moderated by Mr Anant Prakash Pandey, Joint Secretary, Ministry of Tribal Affairs, Govt of India, alongside a distinguished panel of policymakers and industry leaders.

The discussion underscored the importance of collaboration between government, industry, and global partners to build sustainable export pathways for tribal products and heritage knowledge.

@barsebrajesh @TribalAffairsIn @moayush @TheAsiaGroup @GopalNadadur @USAmbKeshap @earth2miller @Usibc_md @sandymaini

[U.S.-India Business Council @USIBC]

USIBC hosted a distinguished delegation from the American Intellectual Property Law Association (AIPLA) at our New Delhi office for a high-impact roundtable on Emerging Intellectual Property Issues & Proposed Amendments in IP Laws.

This session was hosted by Dr Brajesh Barse, Director, Lifesciences, USIBC and convened leading global IP practitioners, industry representatives and policy experts for a forward-looking exchange on strengthening India’s intellectual property landscape. The discussion focused on evolving regulatory frameworks, key industry challenges and actionable pathways to foster an innovation-driven, globally aligned IP ecosystem.

We were happy to welcome the delegation led by Salvatore Anastasi, President, AIPLA; Sang Yoon Kang, Chair, Asia-Pacific Committee (APC); and Divyendu Verma, Vice Chair, APC & Chair of the India Sub-committee, along with eminent members representing the Asia-Pacific region. Their insights and global perspectives added immense value to the dialogue.

As part of USIBC's continued commitment to advancing a robust, predictable and innovation-friendly IP framework in India, this engagement underscores the importance of cross-border collaboration in shaping future-ready policies.

@aipla @USAmbKeshap @earth2miller @Usibc_md @sandymaini @barsebrajesh

[Ambassador Sergio Gor @USAmbIndia]

Congratulations to @USIBC on 50 years of advancing U.S.-India trade relationship! Proud to mark this milestone at the New Delhi Summit and celebrate the role of American businesses in strengthening our partnership.

[All India Radio News @airnewsalerts]

External Affairs Minister @DrSJaishankar interacts with the US-India Business Council Global Board of Directors Mission in New Delhi.

EAM said that it was encouraging to witness the optimism among business leaders, despite global headwinds, about the present and future of the India - US economic partnership.

[Dr. S. Jaishankar @DrSJaishankar]

Interacted with the @USIBC Global Board of Directors Mission in New Delhi today.

Encouraging to witness the optimism among business leaders, despite global headwinds, about the present and future of the 🇮🇳-🇺🇸 economic partnership.

[U.S.-India Business Council @USIBC]

The U.S-India Business Council (USIBC) congratulates the U.S. and the Indian governments for putting in place a framework for an Interim Agreement regarding reciprocal and mutually beneficial trade (Interim Agreement).

The framework, as a joint statement said, reaffirms the countries’ commitment to the broader U.S.-India Bilateral Trade Agreement (BTA) negotiations, launched by President Donald J. Trump and Prime Minister Narendra Modi on February 13, 2025, which will include additional market access commitments and support more resilient supply chains.

“The Interim Agreement between the United States and India will represent a historic milestone in our countries’ partnership, demonstrating a common commitment to reciprocal and balanced trade based on mutual interests and concrete outcomes,” the statement said.

#USIndiaTradeDeal #USIndiaPartnership

@PiyushGoyal @USAmbIndia @SergioGor @CimGOI @IndianEmbassyUS @USTradeRep

@USAmbKeshap @Usibc_md @earth2miller

[U.S.-India Business Council @USIBC]

USIBC President @USAmbKeshap speaks to @Parikshitl on @CNBCTV18News on U.S.-India Trade Deal, noting it will accelerate the strong momentum in the bilateral partnership. #GlobalLens

[U.S.-India Business Council @USIBC]

Sameer Guduru (@sameerguduru) represented USIBC and moderated a panel discussion titled Renewable Energy Powering AI Infrastucture, Green Data Centres Landscape in India at the 2nd AI in RE Summit, organized by National Solar Energy Federation of India in partnership with Amazon. The panelists included:

Mr. Nimesh Thakur (NTT Global Data Centers)
Mr. Amit Kumar Mittal (Jindal India Renewable Energy)
Mr. Sandeep Das (Hero Future Energies)
Mr. Gurpreet Chugh, CFA (ICF) and
Mr. Pankaj Srivastava (Evren)

The key takeaways include:

1.⁠ ⁠Scalability of renewable energy infrastructure to meet the uninterrupted power requirements of the data centres that are growing rapidly.

2.⁠ ⁠Predictability of renewable energy output considering their variability from day to day as well as from season to season.

3.⁠ ⁠Optimization of powering infrastructure including renewables to ensure optimal CapEx & OpEx particularly for power producers, which may significantly impact PPAs.

4.⁠ ⁠Adhering to global best practices, standards, benchmarking for data centre operations in view of sustainability, energy efficiency, minimizing environmental impact.

5.⁠ ⁠Easing regulation, single window clearances, right of way, powering infrastructure across state boundaries, easing barriers for creation of grid level BESS, standalone categorization & single standard across states.

6.⁠ ⁠Solutions with scalability for managing grids including AI adoption, optimazation algorithms, cybersecurity & treatment of data centre and associated powering infrastructure as critical infrastructure.

Thank you Subramanyam Pulipaka, NSEFI & USIBC member company Amazon for the opportunity!

@NSEFI_official @amazonIN @amazon @NTT_GlobalDC
@JindalRenewable @HeroFuture_HFE @gschugh @officialindiaai

[U.S.-India Business Council @USIBC]

As part of the ongoing USIBC Life Sciences Mission, our delegation had the privilege of meeting Dr. Rajeev Singh Raghuvanshi, DCGI, and the esteemed CDSCO leadership team.

The delegation was led by Dr. Brajesh Barse, Director, Life Sciences, USIBC, and joined by senior representatives from leading pharmaceutical and medical device members companies.

This interaction marked one of the most transparent, constructive, and solutions-oriented engagements we have experienced. Member companies were able to present their regulatory priorities directly to Dr. Rajeev Raghuvanshi, DCGI, and the CDSCO team, and we truly appreciated the clarity, openness, and collaborative spirit throughout the meeting.

We also witnessed quick resolution of some pending issues, demonstrating the commitment, responsiveness, and deep technical understanding that CDSCO brings to India’s evolving regulatory ecosystem.

A special acknowledgment to Dr. Rajeev Raghuvanshi, whose leadership, vision, and continued support for industry–regulator collaboration play a pivotal role in strengthening India’s healthcare and life sciences landscape.

The cooperation and insight shared by the CDSCO, Ministry of Health & Family Welfare, and the broader regulatory team on topics such as import challenges, Level Playing Field (LPF), data protection, and pathways for innovative therapies and devices were invaluable for participating companies.
A big thank you to the entire CDSCO leadership and to our USIBC member companies for their active participation and continued trust in our mission.

@CDSCO_INDIA_INF @MoHFW_INDIA @Usibc_md @sandymaini @barsebrajesh
@Akanksh73835613 @MoHFW_INDIA @Pharmadept @nppa_india @NITIAayog @MEAIndia @CimGOI
@DPIITGoI @DBTIndia @DghsIndia @AyushmanNHA @BIRAC_2012 @AbbVie @GSK @Johnson @AbbottNews @Baxter @Pfizer @Bioconlimited
@Medtronic @SyngeneIntl @Baxter @MSD
@TheAsiaGroup @BhartiaJubilant @illumina @EliLillyandCo

#DCGI #CDSCO #DrRajeevSinghRaghuvanshi #InstitutionalVisit #FacultyInteraction #FacilityView #ScientificCollaboration #GovernmentOfIndia #MCOPS #MAHE #Manipal #USIndia #LifeSciences #Healthcare #Pharma #MedTech #NPPA #USIBC #AffordableMedicinesForAll #Pharma #MedTech #Innovation #RegulatoryReform #LifeSciences

[U.S.-India Business Council @USIBC]

And that’s a wrap from team #USIBC!

#BTS2025 #USIBCxBTS #USIndiaTech #USIndiaPartnership #Bengaluru

@USAmbKeshap @earth2miller @Usibc_md @adityakaushik00 @sameerguduru @AditiAnarayanan @YaminiJindal @nikitachawla87 @jahaaanvi

[U.S.-India Business Council @USIBC]

🇺🇸🇮🇳 The U.S.–India Business Council’s (USIBC) Life Sciences Policy Mission begins in New Delhi.
Engaging discussions on healthcare innovation with leaders from the Ministry of External Affairs (MEA), Corporate Law Group (CLG), and USIBC.

#USIndia #LifeSciences #Healthcare #Innovation #Pharma #Biotech #PublicHealth #Collaboration #USIBC #MEA #CLG #HealthcareInnovation #India

@Usibc_md @sandymaini @barsebrajesh @Akanksh73835613 @MEABharat @TheCLMalliance

[U.S.-India Business Council @USIBC]

As part of the USIBC Life Sciences Policy Mission 2025, led by Sandeep Maini, Executive Director – USIBC, and Dr. Brajesh Barse, Director – Life Sciences, the delegation had a fruitful meeting with Dr. Rajendra Panduranga Joshi, Additional DGHS, Ministry of Health & Family Welfare.

The discussion focused on advancing cooperation in genomics initiatives, Global Tender Enquiry (GTE) processes, for pharmaceuticals and medical devices, refurbished Medical device import and fostering innovation in new disease areas.

USIBC member companies also shared their ongoing efforts and keen interest in strengthening adult immunization programs, expanding digital health adoption, and collaborating with DGHS on new initiatives to enhance healthcare outcomes in India.

We thank Dr. Joshi for his valuable guidance and partnership in supporting innovation-driven growth in India’s healthcare ecosystem.

#LifeSciences #Healthcare #Pharma #USIndiaPartnership #PolicyDialogue #Innovation

@abbvie @GSK @pfizer @Bioconlimited @Medtronic @SyngeneIntl @JNJNews

@MoHFW_INDIA @USAmbKeshap @earth2miller @Usibc_md @sandymaini @barsebrajesh

[U.S.-India Business Council @USIBC]

As part of the USIBC Life Sciences Policy Mission 2025, led by Sandeep Maini, Executive Director, USIBC, and Dr Brajesh Barse, Director,  Life Sciences, the delegation had an insightful and engaging discussion with Shri Amit Agrawal, Secretary, Department of Pharmaceuticals (DoP).

The dialogue focused on strengthening collaboration between the government, academia, and industry to foster innovation and develop a skilled life sciences workforce. Key areas of discussion included the PRIP scheme, partnerships with NIPERs, and co-creation of study modules and research agendas by companies to enhance students’ applied science capabilities.

Member companies shared perspectives on empowering students, promoting industry-academia linkages, and addressing key regulatory and operational issues across the pharmaceutical and medical device sectors.

We thank Secretary Amit Agrawal and the DoP team for their forward-looking approach and continued partnership in advancing India’s leadership in the global life sciences ecosystem.

@BMS @AbbVie @GSK @Johnson @Abbott @Baxter @Pfizer @Jubilant @Medtronic @Biocon @MSD @Syngene

@sandymaini @barsebrajesh @Usibc_md @Akanksh73835613 @USAmbKeshap @Pharmadept @MoHFW_INDIA @DghsIndia

[U.S.-India Business Council @USIBC]

As part of the ongoing USIBC Life Sciences Policy Mission 2025, the delegation had an engaging and productive meeting with Dr. Sunil Kumar Barnwal, CEO, National Health Authority (NHA).

The discussion centered on enhancing public–private collaboration in the pharmaceutical and medical device sectors, aligning industry efforts with NHA’s digital health and healthcare access programs, and exploring opportunities to integrate innovative technologies to strengthen Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)and India’s broader healthcare delivery systems.

USIBC member companies shared perspectives on driving innovation, improving affordability, and building resilient healthcare infrastructure through U.S.–India partnerships.

We thank Dr. Barnwal and the NHA team for their continued collaboration and openness to strengthen partnerships for accessible and technology-driven healthcare in India.

Participating companies:
@BMS @AbbVie @GSK @Johnson @Abbott
@Baxter @Pfizer @Jubilant @Medtronic @Biocon
@MSD @Syngene @TheAsiaGroup

@AyushmanNHA @USAmbKeshap @Usibc_md @sandymaini @barsebrajesh @BMS @AbbVie @GSK @Johnson @Abbott @Baxter @Pfizer @Jubilant @Medtronic @Biocon @MSD @Syngene @sandymaini @barsebrajesh @Usibc_md @Akanksh73835613
@Pharmadept @MoHFW_INDIA @DghsIndia

[U.S.-India Business Council @USIBC]

🇺🇸🇮🇳 At USIBC’s Life Sciences Mission, Shri Darpan Jain, Joint Secretary (Dept. of Commerce) B M Mishra, and Joint Secretary, underscored the realities shaping India’s pricing and regulatory framework, including how patient assistance programs operate and why drug and device pricing need distinct approaches.

U.S.–India cooperation continues to play a vital role as both countries work toward stronger global standards, innovation, and better patient access.

#USIndia #LifeSciences #Healthcare #MedTech #Pharma #Innovation #USIBC

@Usibc_md @sandymaini @barsebrajesh @Akanksh73835613 @Pharmadept @NITIAayog @MEAIndia @CimGOI @DPIITGoI @MoHFW_INDIA @DBTIndia @DghsIndia @AyushmanNHA @BIRAC_2012

@AbbVie @GSK @Johnson @Abbott @Baxter @Pfizer @Bioconlimited @Medtronic @SyngeneIntl @Baxter @MSD @TheAsiaGroup @BhartiaJubilant @illumina @EliLillyandCo

[U.S.-India Business Council @USIBC]

USIBC’s Life Sciences Mission 2025 delegation met Ms. Punya Salila Srivastava, Secretary, Department of Health (MoHFW), at Nirman Bhawan, New Delhi, for a focused stakeholder interaction.

Industry representatives highlighted priorities including clearer patent visibility at the state level, more efficient regulatory pathways, and stronger quality systems.

The conversation also emphasised the importance of a transparent digital drug-regulation platform, strengthened and ethical clinical-trial ecosystems, and deeper collaboration on cancer care, vaccines, and innovation-led health solutions.

#USIndia #Healthcare #Pharma #MedTech #Innovation #RegulatoryReform #LifeSciences

@Usibc_md @sandymaini @barsebrajesh @Akanksh73835613 @MoHFW_INDIA

@Pharmadept @NITIAayog @MEAIndia @CimGOI @DPIITGoI
@DBTIndia @DghsIndia @AyushmanNHA @BIRAC_2012

@AbbVie @GSK @Johnson @Abbott @Baxter @Pfizer
@Bioconlimited @Medtronic @SyngeneIntl @Baxter
@MSD @TheAsiaGroup @BhartiaJubilant @illumina
@EliLillyandCo

[U.S.-India Business Council @USIBC]

🇺🇸🇮🇳 The USIBC Life Sciences Mission met Shri P. Krishnamurthy, Chairman, NPPA, for an engaging discussion.

Industry leaders shared perspectives on balancing affordability with innovation, highlighting areas for deeper U.S.–India alignment.

The conversation also covered India’s pricing landscape, regulatory predictability, and pathways to support patient access.

#USIndia #LifeSciences #Healthcare #Pharma #MedTech #NPPA #USIBC #AffordableMedicinesForAll #Pharma #MedTech #Innovation #RegulatoryReform #LifeSciences

@nppa_india @Usibc_md @sandymaini @barsebrajesh @Akanksh73835613 @MoHFW_INDIA @Pharmadept
@NITIAayog @MEAIndia @CimGOI @DPIITGoI
@DBTIndia @DghsIndia @AyushmanNHA @BIRAC_2012 @AbbVie @GSK @Johnson
@Abbott @Baxter @Pfizer @Bioconlimited @Medtronic @SyngeneIntl @Baxter
@MSD @TheAsiaGroup @BhartiaJubilant
@illumina @EliLillyandCo

[U.S.-India Business Council @USIBC]

🇮🇳🇺🇸The USIBC Life Sciences Mission met Smt. Himani Pande, Additional Secretary, DPIIT, for an in-depth discussion on India’s innovation and regulatory landscape.

Key themes included upcoming task-force inputs, clinical-trial processes, capacity gaps, and options around exclusion lists, duty exemptions, and support for research institutions.

Industry leaders also highlighted the importance of regulatory data protection, streamlined documentation pathways, and security-related clearances affecting manufacturers.

#USIndia #LifeSciences #Healthcare #Pharma #MedTech #Innovation #RegulatoryReform #DPIIT #USIBC

#USIndia #LifeSciences #Healthcare #Pharma #MedTech #NPPA #USIBC #AffordableMedicinesForAll #Pharma #MedTech #Innovation #RegulatoryReform #LifeSciences

@Usibc_md @sandymaini @barsebrajesh @Akanksh73835613 @MoHFW_INDIA
@Pharmadept @NITIAayog @MEAIndia @CimGOI @DPIITGoI @DBTIndia @DghsIndia @AyushmanNHA
@BIRAC_2012 @AbbVie @GSK @Johnson @Abbott @Baxter @Pfizer @Bioconlimited @Medtronic
@SyngeneIntl @Baxter @MSD @nppa_india
@BhartiaJubilant @illumina @EliLillyandCo

[Dr. Brajesh Barse @barsebrajesh]

US-India Agriculture Working Group launched https://t.co/m1jxod0tLm